Endosonics Corp

EndoSonics Corp. agreed to buy Cardiometrics Inc. for about $67 million in cash and stock in a transaction combining two makers of medical devices to treat cardiovascular disease. Under the terms of the agreement, EndoSonics' offer is valued at $9 a share, based on Friday's closing stock prices. EndoSonics said it will exchange 0.35 newly issued share, 0.20 share of its CardioVascular Dynamics Inc. subsidiary and $2 in cash for each share of Cardiometrics Inc. Cardiometrics shares rose $1.

Jomed, one of Europe's top medical devices maker, on Sunday agreed to acquire Rancho Cordova-based EndoSonics Corp. for about $205 million in a move to help the Swiss firm penetrate the U.S. market more effectively. The companies said in a joint release that Jomed will pay $11 per share for the outstanding stock of EndoSonics.

Jomed, one of Europe's top medical devices maker, on Sunday agreed to acquire Rancho Cordova-based EndoSonics Corp. for about $205 million in a move to help the Swiss firm penetrate the U.S. market more effectively. The companies said in a joint release that Jomed will pay $11 per share for the outstanding stock of EndoSonics.

EndoSonics Corp. said it will distribute to its shareholders an 8% stake in Irvine-based CardioVascular Dynamics Inc., which once was owned by the Rancho Cordova company. The move will cut EndoSonics' stake in CardioVascular to 25%, or 2.21 million shares, from 33%. CardioVascular makes devices to strengthen blood vessels. EndoSonics, which makes ultrasound imaging systems, spun off most of CardioVascular in June 1996.

EndoSonics Corp. said it will distribute to its shareholders an 8% stake in Irvine-based CardioVascular Dynamics Inc., which once was owned by the Rancho Cordova company. The move will cut EndoSonics' stake in CardioVascular to 25%, or 2.21 million shares, from 33%. CardioVascular makes devices to strengthen blood vessels. EndoSonics, which makes ultrasound imaging systems, spun off most of CardioVascular in June 1996.

Michael Henson spends his life talking to heart doctors. He vacations with them. He watches them work. The chief executive said he recently "spent all day in a catheter lab, with my suit off, with greens on, watching cardiologists putting catheters in patients." Such attention to detail is one reason the young Irvine company he runs, CardioVascular Dynamics Inc., is experiencing sudden growth. Sales this year are expected to hit $8 million, double 1995's results.

Vons Cos. is expected today to respond to Safeway Inc.'s offer to buy the Southern California supermarket chain for $2.29 billion cash and assumed debt. . . . Rancho Cordova-based EndoSonics Corp. named Roger Salquist chairman. . . . Chatsworth-based StreamLogic Corp. appointed Barbara V. Scherer chief financial officer. . . Keith T. Davidson has been named president of Torrance-based Xplor International. . . . Irvine-based Subscriber Computing Inc.

Radiance Medical Systems Inc. plans to sell about 2.85 million shares of common stock, according to a registration statement filed with the Securities and Exchange Commission. The stock sale will include 1.5 million shares that the company will offer and about 1.35 million shares that its former parent company, EndoSonics Corp., will sell, according to the filing. The 1.35 million shares represent EndoSonics' entire stake in Radiance Medical.

EndoSonics Corp. agreed to buy Cardiometrics Inc. for about $67 million in cash and stock in a transaction combining two makers of medical devices to treat cardiovascular disease. Under the terms of the agreement, EndoSonics' offer is valued at $9 a share, based on Friday's closing stock prices. EndoSonics said it will exchange 0.35 newly issued share, 0.20 share of its CardioVascular Dynamics Inc. subsidiary and $2 in cash for each share of Cardiometrics Inc. Cardiometrics shares rose $1.

Michael Henson spends his life talking to heart doctors. He vacations with them. He watches them work. The chief executive said he recently "spent all day in a catheter lab, with my suit off, with greens on, watching cardiologists putting catheters in patients." Such attention to detail is one reason the young Irvine company he runs, CardioVascular Dynamics Inc., is experiencing sudden growth. Sales this year are expected to hit $8 million, double 1995's results.

Radiance Medical Systems Inc. said Tuesday that its offering of 2.8 million shares of common stock was priced at $9.50 a share. The Irvine company offered 1.5 million of its shares, raising nearly $13.4 million. The remaining 1.35 million shares were owned by former parent EndoSonics Corp., which is unloading its entire stake in Radiance. Radiance will use the proceeds from its 1.

CardioVascular Dynamics Inc. said Wednesday that it is forming a spinoff company to develop products for using radioactive materials to treat blood vessels. The Irvine biomedical company said the offspring, Radiis Inc., will be housed close to its own corporate headquarters. The parent will license Radiis to develop the products using radioactive materials to prevent surgically unclogged vessels from clogging up again.